nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.1	0.136	CbGbCtD
Valganciclovir—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0895	0.121	CbGbCtD
Valganciclovir—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0865	0.117	CbGbCtD
Valganciclovir—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0797	0.108	CbGbCtD
Valganciclovir—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0771	0.104	CbGbCtD
Valganciclovir—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0761	0.103	CbGbCtD
Valganciclovir—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0687	0.0929	CbGbCtD
Valganciclovir—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0655	0.0886	CbGbCtD
Valganciclovir—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0514	0.0695	CbGbCtD
Valganciclovir—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0443	0.0599	CbGbCtD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—type 2 diabetes mellitus	0.00369	0.0879	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.00217	0.0518	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00143	0.034	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.00112	0.0267	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.00108	0.0257	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.00103	0.0245	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.00103	0.0245	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000971	0.0231	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000954	0.0227	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000779	0.0186	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000739	0.0176	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.0007	0.0167	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000648	0.0154	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000626	0.0149	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000614	0.0146	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000548	0.0131	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000533	0.0127	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.00051	0.0122	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000494	0.0118	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000491	0.0117	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000459	0.0109	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000426	0.0102	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000418	0.00995	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000412	0.00982	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000403	0.00961	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000395	0.00942	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000344	0.00819	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000339	0.00808	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000336	0.00799	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000331	0.00788	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000329	0.00784	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.00032	0.00763	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000318	0.00758	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000318	0.00758	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000316	0.00753	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000313	0.00745	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000307	0.00732	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000307	0.0073	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000305	0.00726	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000296	0.00705	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000291	0.00693	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000284	0.00678	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000275	0.00654	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.00026	0.00619	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000259	0.00618	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000259	0.00618	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00025	0.00594	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00025	0.00594	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000249	0.00593	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000245	0.00584	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000241	0.00575	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000233	0.00556	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000232	0.00553	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000227	0.0054	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000224	0.00533	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000217	0.00516	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000216	0.00513	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000212	0.00505	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000212	0.00505	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000205	0.00488	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000198	0.0047	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000196	0.00468	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000191	0.00454	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000183	0.00437	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000177	0.00422	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000171	0.00406	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000163	0.00388	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000163	0.00388	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000159	0.00379	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000159	0.00378	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000158	0.00376	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000157	0.00374	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000156	0.00371	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000152	0.00361	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00015	0.00358	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00015	0.00358	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000148	0.00352	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000147	0.00351	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000145	0.00344	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000141	0.00335	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00014	0.00333	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00014	0.00333	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000138	0.0033	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000138	0.00328	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000137	0.00327	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000132	0.00315	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.000129	0.00307	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000128	0.00306	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000128	0.00304	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000127	0.00302	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000123	0.00293	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000123	0.00292	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000123	0.00292	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000118	0.00281	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000118	0.00281	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000118	0.00281	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000116	0.00276	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000114	0.00272	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000114	0.00271	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000114	0.00271	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00011	0.00261	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00011	0.00261	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000109	0.00261	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000109	0.0026	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000109	0.00259	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000108	0.00256	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000108	0.00256	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000107	0.00255	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000104	0.00248	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.0001	0.00239	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.0001	0.00239	CbGpPWpGaD
Valganciclovir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0001	0.000457	CcSEcCtD
Valganciclovir—Headache—Glimepiride—type 2 diabetes mellitus	9.98e-05	0.000456	CcSEcCtD
Valganciclovir—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.97e-05	0.000455	CcSEcCtD
Valganciclovir—Cough—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000455	CcSEcCtD
Valganciclovir—Headache—Sitagliptin—type 2 diabetes mellitus	9.95e-05	0.000455	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	9.95e-05	0.00237	CbGpPWpGaD
Valganciclovir—Anaemia—Losartan—type 2 diabetes mellitus	9.93e-05	0.000454	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.88e-05	0.000451	CcSEcCtD
Valganciclovir—Agitation—Losartan—type 2 diabetes mellitus	9.87e-05	0.000451	CcSEcCtD
Valganciclovir—Oedema—Metformin—type 2 diabetes mellitus	9.87e-05	0.000451	CcSEcCtD
Valganciclovir—Tinnitus—Ramipril—type 2 diabetes mellitus	9.86e-05	0.000451	CcSEcCtD
Valganciclovir—Hypertension—Irbesartan—type 2 diabetes mellitus	9.85e-05	0.00045	CcSEcCtD
Valganciclovir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.83e-05	0.000449	CcSEcCtD
Valganciclovir—Infection—Metformin—type 2 diabetes mellitus	9.81e-05	0.000448	CcSEcCtD
Valganciclovir—Insomnia—Valsartan—type 2 diabetes mellitus	9.8e-05	0.000448	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.76e-05	0.000446	CcSEcCtD
Valganciclovir—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.73e-05	0.000445	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.73e-05	0.00232	CbGpPWpGaD
Valganciclovir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.000444	CcSEcCtD
Valganciclovir—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.72e-05	0.000444	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9.69e-05	0.00231	CbGpPWpGaD
Valganciclovir—Insomnia—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000443	CcSEcCtD
Valganciclovir—Malaise—Losartan—type 2 diabetes mellitus	9.69e-05	0.000443	CcSEcCtD
Valganciclovir—Anxiety—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000442	CcSEcCtD
Valganciclovir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.68e-05	0.000442	CcSEcCtD
Valganciclovir—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.68e-05	0.000442	CcSEcCtD
Valganciclovir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.66e-05	0.000442	CcSEcCtD
Valganciclovir—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.66e-05	0.000441	CcSEcCtD
Valganciclovir—Vertigo—Losartan—type 2 diabetes mellitus	9.65e-05	0.000441	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.65e-05	0.000441	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.65e-05	0.000441	CcSEcCtD
Valganciclovir—Somnolence—Valsartan—type 2 diabetes mellitus	9.64e-05	0.00044	CcSEcCtD
Valganciclovir—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.62e-05	0.000439	CcSEcCtD
Valganciclovir—Leukopenia—Losartan—type 2 diabetes mellitus	9.61e-05	0.000439	CcSEcCtD
Valganciclovir—Discomfort—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000439	CcSEcCtD
Valganciclovir—Skin disorder—Metformin—type 2 diabetes mellitus	9.59e-05	0.000438	CcSEcCtD
Valganciclovir—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000437	CcSEcCtD
Valganciclovir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.54e-05	0.000436	CcSEcCtD
Valganciclovir—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000436	CcSEcCtD
Valganciclovir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000436	CcSEcCtD
Valganciclovir—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.5e-05	0.000434	CcSEcCtD
Valganciclovir—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000434	CcSEcCtD
Valganciclovir—Nausea—Glimepiride—type 2 diabetes mellitus	9.46e-05	0.000432	CcSEcCtD
Valganciclovir—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.45e-05	0.000432	CcSEcCtD
Valganciclovir—Nausea—Sitagliptin—type 2 diabetes mellitus	9.43e-05	0.000431	CcSEcCtD
Valganciclovir—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.43e-05	0.000431	CcSEcCtD
Valganciclovir—Asthenia—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000431	CcSEcCtD
Valganciclovir—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.42e-05	0.00043	CcSEcCtD
Valganciclovir—Anorexia—Metformin—type 2 diabetes mellitus	9.41e-05	0.00043	CcSEcCtD
Valganciclovir—Cough—Losartan—type 2 diabetes mellitus	9.37e-05	0.000428	CcSEcCtD
Valganciclovir—Urticaria—Gliclazide—type 2 diabetes mellitus	9.37e-05	0.000428	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.36e-05	0.000428	CcSEcCtD
Valganciclovir—Alopecia—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000427	CcSEcCtD
Valganciclovir—Fatigue—Valsartan—type 2 diabetes mellitus	9.35e-05	0.000427	CcSEcCtD
Valganciclovir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.000426	CcSEcCtD
Valganciclovir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.000426	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	9.32e-05	0.00222	CbGpPWpGaD
Valganciclovir—Oedema—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000426	CcSEcCtD
Valganciclovir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000426	CcSEcCtD
Valganciclovir—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.31e-05	0.000425	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	9.3e-05	0.00222	CbGpPWpGaD
Valganciclovir—Pruritus—Glyburide—type 2 diabetes mellitus	9.3e-05	0.000425	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	9.29e-05	0.00221	CbGpPWpGaD
Valganciclovir—Mental disorder—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000423	CcSEcCtD
Valganciclovir—Constipation—Valsartan—type 2 diabetes mellitus	9.27e-05	0.000423	CcSEcCtD
Valganciclovir—Infection—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.000423	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.25e-05	0.000422	CcSEcCtD
Valganciclovir—Fatigue—Orlistat—type 2 diabetes mellitus	9.23e-05	0.000422	CcSEcCtD
Valganciclovir—Hypotension—Metformin—type 2 diabetes mellitus	9.22e-05	0.000421	CcSEcCtD
Valganciclovir—Malnutrition—Ramipril—type 2 diabetes mellitus	9.21e-05	0.000421	CcSEcCtD
Valganciclovir—Pain—Orlistat—type 2 diabetes mellitus	9.16e-05	0.000418	CcSEcCtD
Valganciclovir—Arthralgia—Losartan—type 2 diabetes mellitus	9.14e-05	0.000418	CcSEcCtD
Valganciclovir—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.14e-05	0.000417	CcSEcCtD
Valganciclovir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000417	CcSEcCtD
Valganciclovir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.12e-05	0.000417	CcSEcCtD
Valganciclovir—Anxiety—Losartan—type 2 diabetes mellitus	9.11e-05	0.000416	CcSEcCtD
Valganciclovir—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000415	CcSEcCtD
Valganciclovir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.05e-05	0.000414	CcSEcCtD
Valganciclovir—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000413	CcSEcCtD
Valganciclovir—Tension—Ramipril—type 2 diabetes mellitus	9.04e-05	0.000413	CcSEcCtD
Valganciclovir—Discomfort—Losartan—type 2 diabetes mellitus	9.04e-05	0.000413	CcSEcCtD
Valganciclovir—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000412	CcSEcCtD
Valganciclovir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.01e-05	0.000411	CcSEcCtD
Valganciclovir—Headache—Bromocriptine—type 2 diabetes mellitus	9e-05	0.000411	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9e-05	0.00214	CbGpPWpGaD
Valganciclovir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.99e-05	0.000411	CcSEcCtD
Valganciclovir—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.99e-05	0.000411	CcSEcCtD
Valganciclovir—Nervousness—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000409	CcSEcCtD
Valganciclovir—Dry mouth—Losartan—type 2 diabetes mellitus	8.94e-05	0.000409	CcSEcCtD
Valganciclovir—Anorexia—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000406	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000405	CcSEcCtD
Valganciclovir—Paraesthesia—Metformin—type 2 diabetes mellitus	8.86e-05	0.000405	CcSEcCtD
Valganciclovir—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.85e-05	0.000405	CcSEcCtD
Valganciclovir—Confusional state—Losartan—type 2 diabetes mellitus	8.84e-05	0.000404	CcSEcCtD
Valganciclovir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000403	CcSEcCtD
Valganciclovir—Dyspnoea—Metformin—type 2 diabetes mellitus	8.8e-05	0.000402	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.78e-05	0.00209	CbGpPWpGaD
Valganciclovir—Somnolence—Metformin—type 2 diabetes mellitus	8.78e-05	0.000401	CcSEcCtD
Valganciclovir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.77e-05	0.000401	CcSEcCtD
Valganciclovir—Oedema—Losartan—type 2 diabetes mellitus	8.77e-05	0.000401	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.76e-05	0.0004	CcSEcCtD
Valganciclovir—Infection—Losartan—type 2 diabetes mellitus	8.71e-05	0.000398	CcSEcCtD
Valganciclovir—Hypotension—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000398	CcSEcCtD
Valganciclovir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.69e-05	0.000397	CcSEcCtD
Valganciclovir—Dyspepsia—Metformin—type 2 diabetes mellitus	8.69e-05	0.000397	CcSEcCtD
Valganciclovir—Tremor—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000394	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	8.63e-05	0.00205	CbGpPWpGaD
Valganciclovir—Urticaria—Valsartan—type 2 diabetes mellitus	8.61e-05	0.000393	CcSEcCtD
Valganciclovir—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.6e-05	0.000393	CcSEcCtD
Valganciclovir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.58e-05	0.000392	CcSEcCtD
Valganciclovir—Decreased appetite—Metformin—type 2 diabetes mellitus	8.58e-05	0.000392	CcSEcCtD
Valganciclovir—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.57e-05	0.000391	CcSEcCtD
Valganciclovir—Tachycardia—Losartan—type 2 diabetes mellitus	8.56e-05	0.000391	CcSEcCtD
Valganciclovir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.55e-05	0.00039	CcSEcCtD
Valganciclovir—Nausea—Bromocriptine—type 2 diabetes mellitus	8.54e-05	0.00039	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.52e-05	0.000389	CcSEcCtD
Valganciclovir—Fatigue—Metformin—type 2 diabetes mellitus	8.51e-05	0.000389	CcSEcCtD
Valganciclovir—Urticaria—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000389	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000388	CcSEcCtD
Valganciclovir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.47e-05	0.000387	CcSEcCtD
Valganciclovir—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.47e-05	0.000387	CcSEcCtD
Valganciclovir—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.47e-05	0.000387	CcSEcCtD
Valganciclovir—Asthenia—Gliclazide—type 2 diabetes mellitus	8.46e-05	0.000387	CcSEcCtD
Valganciclovir—Agitation—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000387	CcSEcCtD
Valganciclovir—Constipation—Metformin—type 2 diabetes mellitus	8.44e-05	0.000386	CcSEcCtD
Valganciclovir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000382	CcSEcCtD
Valganciclovir—Anorexia—Losartan—type 2 diabetes mellitus	8.36e-05	0.000382	CcSEcCtD
Valganciclovir—Vomiting—Glyburide—type 2 diabetes mellitus	8.35e-05	0.000382	CcSEcCtD
Valganciclovir—Pruritus—Gliclazide—type 2 diabetes mellitus	8.35e-05	0.000381	CcSEcCtD
Valganciclovir—Malaise—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000379	CcSEcCtD
Valganciclovir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000379	CcSEcCtD
Valganciclovir—Somnolence—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000378	CcSEcCtD
Valganciclovir—Dermatitis—Glyburide—type 2 diabetes mellitus	8.28e-05	0.000378	CcSEcCtD
Valganciclovir—Vertigo—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000378	CcSEcCtD
Valganciclovir—Leukopenia—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000377	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.23e-05	0.00196	CbGpPWpGaD
Valganciclovir—Headache—Glyburide—type 2 diabetes mellitus	8.23e-05	0.000376	CcSEcCtD
Valganciclovir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000375	CcSEcCtD
Valganciclovir—Hypotension—Losartan—type 2 diabetes mellitus	8.19e-05	0.000374	CcSEcCtD
Valganciclovir—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.13e-05	0.000372	CcSEcCtD
Valganciclovir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.00037	CcSEcCtD
Valganciclovir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.07e-05	0.000369	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.07e-05	0.000369	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	8.07e-05	0.00192	CbGpPWpGaD
Valganciclovir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000367	CcSEcCtD
Valganciclovir—Cough—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000367	CcSEcCtD
Valganciclovir—Fatigue—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000367	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.99e-05	0.000365	CcSEcCtD
Valganciclovir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000365	CcSEcCtD
Valganciclovir—Convulsion—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000365	CcSEcCtD
Valganciclovir—Constipation—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000364	CcSEcCtD
Valganciclovir—Pain—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000364	CcSEcCtD
Valganciclovir—Insomnia—Losartan—type 2 diabetes mellitus	7.93e-05	0.000362	CcSEcCtD
Valganciclovir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000361	CcSEcCtD
Valganciclovir—Paraesthesia—Losartan—type 2 diabetes mellitus	7.87e-05	0.00036	CcSEcCtD
Valganciclovir—Urticaria—Metformin—type 2 diabetes mellitus	7.84e-05	0.000358	CcSEcCtD
Valganciclovir—Arthralgia—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000358	CcSEcCtD
Valganciclovir—Dyspnoea—Losartan—type 2 diabetes mellitus	7.82e-05	0.000357	CcSEcCtD
Valganciclovir—Anxiety—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000357	CcSEcCtD
Valganciclovir—Nausea—Glyburide—type 2 diabetes mellitus	7.8e-05	0.000357	CcSEcCtD
Valganciclovir—Abdominal pain—Metformin—type 2 diabetes mellitus	7.8e-05	0.000356	CcSEcCtD
Valganciclovir—Dizziness—Gliclazide—type 2 diabetes mellitus	7.8e-05	0.000356	CcSEcCtD
Valganciclovir—Somnolence—Losartan—type 2 diabetes mellitus	7.79e-05	0.000356	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000356	CcSEcCtD
Valganciclovir—Asthenia—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000355	CcSEcCtD
Valganciclovir—Discomfort—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000354	CcSEcCtD
Valganciclovir—Dyspepsia—Losartan—type 2 diabetes mellitus	7.72e-05	0.000353	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.7e-05	0.00183	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.7e-05	0.00183	CbGpPWpGaD
Valganciclovir—Asthenia—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000351	CcSEcCtD
Valganciclovir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000351	CcSEcCtD
Valganciclovir—Pruritus—Valsartan—type 2 diabetes mellitus	7.67e-05	0.00035	CcSEcCtD
Valganciclovir—Dry mouth—Ramipril—type 2 diabetes mellitus	7.67e-05	0.00035	CcSEcCtD
Valganciclovir—Decreased appetite—Losartan—type 2 diabetes mellitus	7.62e-05	0.000348	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000348	CcSEcCtD
Valganciclovir—Confusional state—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000346	CcSEcCtD
Valganciclovir—Pruritus—Orlistat—type 2 diabetes mellitus	7.58e-05	0.000346	CcSEcCtD
Valganciclovir—Fatigue—Losartan—type 2 diabetes mellitus	7.56e-05	0.000345	CcSEcCtD
Valganciclovir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000343	CcSEcCtD
Valganciclovir—Oedema—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000343	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	7.52e-05	0.00179	CbGpPWpGaD
Valganciclovir—Vomiting—Gliclazide—type 2 diabetes mellitus	7.5e-05	0.000343	CcSEcCtD
Valganciclovir—Constipation—Losartan—type 2 diabetes mellitus	7.5e-05	0.000342	CcSEcCtD
Valganciclovir—Pain—Losartan—type 2 diabetes mellitus	7.5e-05	0.000342	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.49e-05	0.00178	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.47e-05	0.00178	CbGpPWpGaD
Valganciclovir—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.43e-05	0.00034	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.43e-05	0.00177	CbGpPWpGaD
Valganciclovir—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000339	CcSEcCtD
Valganciclovir—Urticaria—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000338	CcSEcCtD
Valganciclovir—Headache—Gliclazide—type 2 diabetes mellitus	7.39e-05	0.000338	CcSEcCtD
Valganciclovir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000337	CcSEcCtD
Valganciclovir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000336	CcSEcCtD
Valganciclovir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000336	CcSEcCtD
Valganciclovir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000336	CcSEcCtD
Valganciclovir—Tachycardia—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000335	CcSEcCtD
Valganciclovir—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000335	CcSEcCtD
Valganciclovir—Skin disorder—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000334	CcSEcCtD
Valganciclovir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.27e-05	0.000332	CcSEcCtD
Valganciclovir—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.22e-05	0.00033	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.17e-05	0.000328	CcSEcCtD
Valganciclovir—Dizziness—Valsartan—type 2 diabetes mellitus	7.17e-05	0.000327	CcSEcCtD
Valganciclovir—Anorexia—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000327	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.15e-05	0.0017	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.15e-05	0.0017	CbGpPWpGaD
Valganciclovir—Dizziness—Orlistat—type 2 diabetes mellitus	7.08e-05	0.000324	CcSEcCtD
Valganciclovir—Asthenia—Metformin—type 2 diabetes mellitus	7.08e-05	0.000324	CcSEcCtD
Valganciclovir—Hypotension—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000321	CcSEcCtD
Valganciclovir—Nausea—Gliclazide—type 2 diabetes mellitus	7.01e-05	0.00032	CcSEcCtD
Valganciclovir—Pruritus—Metformin—type 2 diabetes mellitus	6.98e-05	0.000319	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.98e-05	0.00166	CbGpPWpGaD
Valganciclovir—Urticaria—Losartan—type 2 diabetes mellitus	6.96e-05	0.000318	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.94e-05	0.00165	CbGpPWpGaD
Valganciclovir—Body temperature increased—Losartan—type 2 diabetes mellitus	6.93e-05	0.000317	CcSEcCtD
Valganciclovir—Abdominal pain—Losartan—type 2 diabetes mellitus	6.93e-05	0.000317	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.9e-05	0.00164	CbGpPWpGaD
Valganciclovir—Vomiting—Valsartan—type 2 diabetes mellitus	6.89e-05	0.000315	CcSEcCtD
Valganciclovir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000314	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000313	CcSEcCtD
Valganciclovir—Dermatitis—Valsartan—type 2 diabetes mellitus	6.83e-05	0.000312	CcSEcCtD
Valganciclovir—Vomiting—Orlistat—type 2 diabetes mellitus	6.81e-05	0.000311	CcSEcCtD
Valganciclovir—Insomnia—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000311	CcSEcCtD
Valganciclovir—Headache—Valsartan—type 2 diabetes mellitus	6.79e-05	0.00031	CcSEcCtD
Valganciclovir—Diarrhoea—Metformin—type 2 diabetes mellitus	6.75e-05	0.000309	CcSEcCtD
Valganciclovir—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000308	CcSEcCtD
Valganciclovir—Dermatitis—Orlistat—type 2 diabetes mellitus	6.75e-05	0.000308	CcSEcCtD
Valganciclovir—Headache—Orlistat—type 2 diabetes mellitus	6.71e-05	0.000307	CcSEcCtD
Valganciclovir—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000306	CcSEcCtD
Valganciclovir—Asthenia—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000305	CcSEcCtD
Valganciclovir—Somnolence—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000305	CcSEcCtD
Valganciclovir—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000302	CcSEcCtD
Valganciclovir—Pruritus—Irbesartan—type 2 diabetes mellitus	6.59e-05	0.000301	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.55e-05	0.00156	CbGpPWpGaD
Valganciclovir—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000299	CcSEcCtD
Valganciclovir—Dizziness—Metformin—type 2 diabetes mellitus	6.53e-05	0.000298	CcSEcCtD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.52e-05	0.00155	CbGpPWpGaD
Valganciclovir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000296	CcSEcCtD
Valganciclovir—Fatigue—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000296	CcSEcCtD
Valganciclovir—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.46e-05	0.000295	CcSEcCtD
Valganciclovir—Nausea—Valsartan—type 2 diabetes mellitus	6.44e-05	0.000294	CcSEcCtD
Valganciclovir—Constipation—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000294	CcSEcCtD
Valganciclovir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000291	CcSEcCtD
Valganciclovir—Nausea—Orlistat—type 2 diabetes mellitus	6.36e-05	0.000291	CcSEcCtD
Valganciclovir—Asthenia—Losartan—type 2 diabetes mellitus	6.29e-05	0.000287	CcSEcCtD
Valganciclovir—Vomiting—Metformin—type 2 diabetes mellitus	6.28e-05	0.000287	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.25e-05	0.00149	CbGpPWpGaD
Valganciclovir—Dermatitis—Metformin—type 2 diabetes mellitus	6.22e-05	0.000284	CcSEcCtD
Valganciclovir—Pruritus—Losartan—type 2 diabetes mellitus	6.2e-05	0.000283	CcSEcCtD
Valganciclovir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000283	CcSEcCtD
Valganciclovir—Headache—Metformin—type 2 diabetes mellitus	6.18e-05	0.000283	CcSEcCtD
Valganciclovir—Dizziness—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000281	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000281	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.08e-05	0.00145	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	6.07e-05	0.00145	CbGpPWpGaD
Valganciclovir—Diarrhoea—Losartan—type 2 diabetes mellitus	6e-05	0.000274	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.99e-05	0.00143	CbGpPWpGaD
Valganciclovir—Urticaria—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000273	CcSEcCtD
Valganciclovir—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000271	CcSEcCtD
Valganciclovir—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000271	CcSEcCtD
Valganciclovir—Vomiting—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.000271	CcSEcCtD
Valganciclovir—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000268	CcSEcCtD
Valganciclovir—Nausea—Metformin—type 2 diabetes mellitus	5.86e-05	0.000268	CcSEcCtD
Valganciclovir—Headache—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000267	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.8e-05	0.00138	CbGpPWpGaD
Valganciclovir—Dizziness—Losartan—type 2 diabetes mellitus	5.8e-05	0.000265	CcSEcCtD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.63e-05	0.00134	CbGpPWpGaD
Valganciclovir—Vomiting—Losartan—type 2 diabetes mellitus	5.57e-05	0.000255	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.56e-05	0.00132	CbGpPWpGaD
Valganciclovir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000253	CcSEcCtD
Valganciclovir—Nausea—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000253	CcSEcCtD
Valganciclovir—Dermatitis—Losartan—type 2 diabetes mellitus	5.52e-05	0.000252	CcSEcCtD
Valganciclovir—Headache—Losartan—type 2 diabetes mellitus	5.49e-05	0.000251	CcSEcCtD
Valganciclovir—Asthenia—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000246	CcSEcCtD
Valganciclovir—Pruritus—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000243	CcSEcCtD
Valganciclovir—Nausea—Losartan—type 2 diabetes mellitus	5.21e-05	0.000238	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.16e-05	0.00123	CbGpPWpGaD
Valganciclovir—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000235	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.14e-05	0.00122	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.09e-05	0.00121	CbGpPWpGaD
Valganciclovir—Dizziness—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000227	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.92e-05	0.00117	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.79e-05	0.00114	CbGpPWpGaD
Valganciclovir—Vomiting—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000218	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.77e-05	0.00114	CbGpPWpGaD
Valganciclovir—Dermatitis—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000216	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.73e-05	0.00113	CbGpPWpGaD
Valganciclovir—Headache—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000215	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.6e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.57e-05	0.00109	CbGpPWpGaD
Valganciclovir—Nausea—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000204	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.27e-05	0.00102	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.15e-05	0.000989	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.89e-05	0.000927	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.85e-05	0.000918	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.61e-05	0.000861	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.09e-05	0.000735	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.86e-05	0.000682	CbGpPWpGaD
